Cha Biotech Files Report on Ownership of Specific Securities by Executives and Major Shareholders
-
Cha Biotech submitted a report on ownership of specific securities by executives and major shareholders, but no specific changes were disclosed.
-
This filing is a routine disclosure obligation and does not contain any material positive or negative information.
KOSDAQ Filing Information
-
Filing: Report on Ownership of Specific Securities by Executives and Major Shareholders
-
Company: CHA Vaccine Research Institute (261780)
-
Submission: Chabiotech Co.,Ltd.
-
Receipt: 05-08-2026